Literature DB >> 30631159

Association between early-stage chronic kidney disease and reduced choroidal thickness in essential hypertensive patients.

Giuseppe Mulè1, Maria Vadalà2, Tiziana La Blasca3, Rossella Gaetani3, Giuseppe Virone3, Marco Guarneri3, Massimo Castellucci2, Giulia Guarrasi2, Micol Terrasi2, Santina Cottone3.   

Abstract

The introduction in the past few years of advanced optical coherence tomography (OCT) techniques has greatly increased our understanding of the choroid, which is the most important vascular layer of the eye. Our study aimed to assess choroidal thickness by using swept-source OCT (SS-OCT) in essential hypertensive patients (EHs) with and without early-stage chronic kidney disease (CKD). We enrolled 100 EHs, of whom 65 were without kidney damage, and 35 had stage 1-3 CKD. In all of the participants, SS-OCT and a routine biochemical workup were performed. Glomerular filtration rate (GFR) was estimated by the CKD Epidemiology Collaboration equation (eGFR). CKD was defined in agreement with the Kidney Disease Outcomes Quality Initiative Kidney Disease: Improving Global Outcomes 2002 guidelines. OCT measurements were performed according to the Early Treatment Diabetic Retinopathy Study (ETDRS) protocol, which divides the macula into nine subfields. The circular grid consists of three concentric rings. EHs with CKD showed thinner choroidal thicknesses than those without it (all p < 0.05), even after adjustment for potential confounding factors. Overall choroidal thickness correlated significantly and directly with eGFR (r = 0.36) and negatively with urinary albumin excretion (r = -0.39). The association of choroidal thickness with CKD was confirmed in multiple logistic regression analyses once the effects of age and other confounding variables were accounted for. The odds ratio of having early-stage CKD associated with a standard deviation increase in overall choroidal thickness was 0.43 (0.24-0.75, 95% confidence interval; p = 0.007). In conclusion, our study confirms the close relationships between changes in ocular microcirculation and renal dysfunction.

Entities:  

Keywords:  Choroid; Hypertensive eye disease; Microcirculation; Renal damage; Renal dysfunction

Mesh:

Year:  2019        PMID: 30631159     DOI: 10.1038/s41440-018-0195-1

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  1 in total

1.  Choroidal Thickness in Eyes with Unilateral Ocular Ischemic Syndrome.

Authors:  Dong Yoon Kim; Soo Geun Joe; Joo Yong Lee; June-Gone Kim; Sung Jae Yang
Journal:  J Ophthalmol       Date:  2015-10-04       Impact factor: 1.909

  1 in total
  10 in total

Review 1.  Arterial Hypertension and the Hidden Disease of the Eye: Diagnostic Tools and Therapeutic Strategies.

Authors:  Rita Del Pinto; Giuseppe Mulè; Maria Vadalà; Caterina Carollo; Santina Cottone; Claudia Agabiti Rosei; Carolina De Ciuceis; Damiano Rizzoni; Claudio Ferri; Maria Lorenza Muiesan
Journal:  Nutrients       Date:  2022-05-25       Impact factor: 6.706

Review 2.  Artificial Intelligence in Predicting Systemic Parameters and Diseases From Ophthalmic Imaging.

Authors:  Bjorn Kaijun Betzler; Tyler Hyungtaek Rim; Charumathi Sabanayagam; Ching-Yu Cheng
Journal:  Front Digit Health       Date:  2022-05-26

Review 3.  Hypertensive eye disease.

Authors:  Carol Y Cheung; Valérie Biousse; Pearse A Keane; Ernesto L Schiffrin; Tien Y Wong
Journal:  Nat Rev Dis Primers       Date:  2022-03-10       Impact factor: 52.329

Review 4.  The eye, the kidney, and cardiovascular disease: old concepts, better tools, and new horizons.

Authors:  Tariq E Farrah; Baljean Dhillon; Pearse A Keane; David J Webb; Neeraj Dhaun
Journal:  Kidney Int       Date:  2020-02-27       Impact factor: 10.612

5.  Relationship Between Renal Function and Choroidal Thickness in Type 2 Diabetic Patients Detected by Swept-Source Optical Coherence Tomography.

Authors:  Sen Liu; Wei Wang; Yan Tan; Miao He; Lanhua Wang; Yuting Li; Wenyong Huang
Journal:  Transl Vis Sci Technol       Date:  2020-04-24       Impact factor: 3.283

6.  Effects of Systemic Profiles on Choroidal Thickness in Treatment-Naïve Eyes With Diabetic Retinopathy.

Authors:  Min Gyu Choi; Hum Chung; Young Hee Yoon; Jee Taek Kim
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-09-01       Impact factor: 4.799

7.  Choroidal Thickness in Diabetes and Diabetic Retinopathy: A Swept Source OCT Study.

Authors:  Wei Wang; Sen Liu; Zhihan Qiu; Miao He; Lanhua Wang; Yuting Li; Wenyong Huang
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-04-09       Impact factor: 4.799

8.  Correlations between choroidal thickness and renal function in patients with retinal vein occlusion.

Authors:  Sang Uk Choi; Ja Young Oh; Jee Taek Kim
Journal:  Sci Rep       Date:  2020-10-08       Impact factor: 4.379

9.  Relationship of choroidal thickness with pulsatile hemodynamics in essential hypertensive patients.

Authors:  Giuseppe Mulè; Maria Vadalà; Nicola Sinatra; Ettore Mancia; Alessandra Sorce; Giulio Geraci; Caterina Carollo; Katia Montalbano; Massimo Castellucci; Giulia Guarrasi; Salvatore Cillino; Santina Cottone
Journal:  J Clin Hypertens (Greenwich)       Date:  2021-01-25       Impact factor: 3.738

10.  Relationship between renal function and prognosis of Chinese proliferative diabetic retinopathy patients undergoing the first vitrectomy: protocol for a prospective cohort study.

Authors:  Chunyan Lei; Keren Zhang; Tiancong Chang; Qibo Ran; Meixia Zhang
Journal:  BMJ Open       Date:  2021-12-06       Impact factor: 2.692

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.